How did Enfusion's revenue and expenses trend in Q4 2024 compared to previous quarters?

Enfusion's revenue and expenses trends in Q4 2024 are not available. However, we can analyze the available data for Q3 2024 to understand the company's financial performance. 1. **Revenue Trend in Q3 2024**: - Enfusion reported $51.17 million in revenue for Q3 2024, which represents a 15.3% year-over-year increase. - The company's revenue was slightly below the Zacks Consensus Estimate of $52.35 million, indicating a surprise of -2.27%. - Enfusion's revenue growth can be attributed to a 17% increase in platform subscriptions and a 1.7% increase in managed services, while other revenues decreased by 36%. 2. **Expense Trend in Q3 2024**: - Enfusion's net income for Q3 2024 was $1.42 million, which represents a 23% decrease from the same quarter in the previous year. - The profit margin decreased to 2.8% from 4.1% in Q3 2023. - Enfusion's earnings per share (EPS) decreased to $0.015 from $0.021 in Q3 2023. 3. **Comparison with Analyst Estimates**: - Enfusion's revenue missed analyst estimates by 1.9%, and the EPS also missed estimates by 36%. - The company's adjusted EBITDA margins expanded, indicating improved operational efficiency. 4. **Overall Performance and Outlook**: - Enfusion's shares have shown a positive performance, with a 0.6% increase over the past month compared to the S&P 500's 0.4% change. - The company has a Zacks Rank #3 (Hold) rating, suggesting a potential to perform in line with the broader market. - Enfusion has revised its full-year revenue guidance to $202-$205 million, indicating a growth forecast of 17% per annum. In conclusion, Enfusion's revenue growth in Q3 2024 was positive, but the company faced challenges in meeting analyst estimates and maintaining profitability. The company's strategic initiatives and geographic expansion are expected to support future growth.